Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fay

Showing results (61-70 of 624) with videos related to

Pageof 63
Sort By:
The Journal of Biological Chemistry|June 2, 2011
Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stabilityHironao Wakabayashi, Amy E Griffiths, Philip J Fay
Advances in Experimental Medicine and Biology|February 23, 1999
All three vasopressin receptor sub-types are expressed by small-cell carcinomaW G North, M J Fay, J Du
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12C Ansong, S M Miles, P J Fay
The Journal of Biological Chemistry|March 3, 1995
Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptaseC Palaniappan, P J Fay, R A Bambara
Methods in Enzymology|January 1, 1993
Factor VIII and factor VIIIaP Lollar, P J Fay, D N Fass
Progress in Clinical and Biological Research|January 1, 1994
Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantationL Pineiro, J Fay, R Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2008
Combining mutations of charged residues at the A2 domain interface enhances factor VIII stability over single point mutationsH Wakabayashi, A E Griffiths, P J Fay
Biochemistry|November 1, 2006
Factor VIII A1 domain residues 97-105 represent a light chain-interactive siteCharles Ansong, Stephen M Miles, Philip J Fay
The Journal of Biological Chemistry|June 10, 2010
Factor VIII lacking the C2 domain retains cofactor activity in vitroHironao Wakabayashi, Amy E Griffiths, Philip J Fay
International Journal of Cell Cloning|September 1, 1991
Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic studyG Miller, T Brashear, M Stone, et al.
Pageof 63

Showing results (61-70 of 624) with videos related to

Sort By:
Pageof 63
The Journal of Biological Chemistry|June 2, 2011
Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stabilityHironao Wakabayashi, Amy E Griffiths, Philip J Fay
Advances in Experimental Medicine and Biology|February 23, 1999
All three vasopressin receptor sub-types are expressed by small-cell carcinomaW G North, M J Fay, J Du
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12C Ansong, S M Miles, P J Fay
The Journal of Biological Chemistry|March 3, 1995
Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptaseC Palaniappan, P J Fay, R A Bambara
Methods in Enzymology|January 1, 1993
Factor VIII and factor VIIIaP Lollar, P J Fay, D N Fass
Progress in Clinical and Biological Research|January 1, 1994
Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantationL Pineiro, J Fay, R Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2008
Combining mutations of charged residues at the A2 domain interface enhances factor VIII stability over single point mutationsH Wakabayashi, A E Griffiths, P J Fay
Biochemistry|November 1, 2006
Factor VIII A1 domain residues 97-105 represent a light chain-interactive siteCharles Ansong, Stephen M Miles, Philip J Fay
The Journal of Biological Chemistry|June 10, 2010
Factor VIII lacking the C2 domain retains cofactor activity in vitroHironao Wakabayashi, Amy E Griffiths, Philip J Fay
International Journal of Cell Cloning|September 1, 1991
Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic studyG Miller, T Brashear, M Stone, et al.
Pageof 63